Allianz’s BioNTech BNTX Stock Holding History

Allianz’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$501K	Hold	5,380	–	–	0.01%	337
2026 Q1	$478K	Hold	5,380	–	–	0.01%	338
2025 Q4	$512K	Hold	5,380	–	–	0.01%	294
2025 Q3	$531K	Sell	5,380 -500	-9%	-$53.5K	0.01%	259
2025 Q2	$626K	Buy	5,880 +5,080	+635%	+$513K	0.01%	237
2025 Q1	$72.8K	Hold	800	–	–	﹤0.01%	350
2024 Q4	$90.1K	Hold	800	–	–	﹤0.01%	364
2024 Q3	$95K	Hold	800	–	–	﹤0.01%	334
2024 Q2	$64.3K	Sell	800 -335	-30%	-$30.6K	﹤0.01%	388
2024 Q1	$105K	Buy	+1,135	New	+$109K	﹤0.01%	367

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Allianz's BNTX Position: Q2 2026 in Review

Allianz held its BioNTech (BNTX) position steady in Q2 2026 at 5,380 shares worth $501K. The position accounts for 0.01% of the portfolio, ranked #337.

Allianz first reported a position in BNTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $626K in Q2 2025. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Allianz held 5,380 shares of BioNTech worth $501K as of Q2 2026.
Allianz left its BioNTech share count unchanged in Q2 2026.
BioNTech made up 0.01% of Allianz's portfolio in Q2 2026, its #337 holding.
Allianz first reported a position in BioNTech in Q1 2024 and has held it in 10 quarters since.
Allianz's BioNTech position peaked at $626K in Q2 2025.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Allianz's 13F filing for Q2 2026, filed 10 Aug 2026.